The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. Hyderabad-based Bharat Biotech